Tagged: Actos

Actos Bladder Cancer Lawsuit

The FDA released a safety announcement on June 15, 2011 informing the public that the use of Takeda Pharmaceutical’s medication Actos (pioglitazone) for diabetes for over a year may be associated with an increased risk of Bladder Cancer from Actos. Takeda’s Actos will now be required to add information about this increased risk of bladder…